{"id":617309,"title":"Consultation for GUI-0080 - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-03-03","captureTimestamp":"2026-03-03T05:27:02.128000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/establishment-licences/drug-establishment-licensing-bulletin/consultation-guidance-0080.html","snippet":"Consultation for GUI-0080 Drug Establishment Licensing Bulletin 165, February 14, 2024 On this page About the consultation Overview of key changes Overview of items under review How to participate About the consultation Health Canada has opened Guidance: How to demonstrate…","rawSnapshotUrl":"/api/snapshots/raw/617309","browseUrl":"https://replay.healtharchive.ca/job-6/20260303052702/https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/establishment-licences/drug-establishment-licensing-bulletin/consultation-guidance-0080.html#ha_snapshot=617309","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}